Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital in connection with the sale of Assessio
Mandate

Vinge advises Main Capital in connection with the sale of Assessio

September 01, 2023 M&A

Vinge advises Main Capital V (“Main Capital”) in connection with the sale of Assessio International Holding 2 AB and its subsidiaries (“Assessio”)

Assessio is a SaaS company specialising in strategic HR and develops tests and tools within work psychology. Their tools can, among other things, help organisations predict who has the best potential to succeed in a role, find future leaders in the organisation and help define their organisational culture and match it with the individuals’ values.

Main Capital acquired Assessio in 2019, and since then, Assessio has doubled its revenue and is today the leading player in talent assessment in both the Nordics and Benelux, with over 1,800 customers across a wide range of industries.

Vinge’s team mainly consisted of Jonas Johansson, Filip Öhrner, Maria Dahlin Kolvik, Per Kling, Stina Bengtsson, Gustav Persson, Johan Gavelin, Sophie Böje, Alexander Rüdén and Anna Ekdahl Roos.

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

 A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023